La. Admin. Code tit. 33 § XV-741
Current through Register Vol. 50, No. 11, November 20, 2024
Section XV-741 - Use of Sources for BrachytherapyA. A licensee shall use the following sources in accordance with the manufacturer's radiation safety and handling instructions: 1. cesium-137 as a sealed source in needles and applicator cells for topical, interstitial, and intracavitary treatment of cancer;2. cobalt-60 as a sealed source in needles and applicator cells for topical, interstitial, and intracavitary treatment of cancer;3. gold-198 as a sealed source in seeds for interstitial treatment of cancer;4. iodine-125 as a sealed source in seeds for interstitial treatment of cancer; and5. iridium-192 as seeds encased in nylon ribbon for interstitial treatment of cancer.B. A licensee shall use only brachytherapy sources for therapeutic medical uses: 1. as approved in the Sealed Source and Device Registry for manual brachytherapy medical use. The manual brachytherapy sources may be used for manual brachytherapy uses that are not explicitly listed in the Sealed Source and Device Registry, but shall be used in accordance with the radiation safety conditions and limitations described in the Sealed Source and Device Registry; or2. in research to deliver therapeutic doses for medical use in accordance with an active Investigational Device Exemption (IDE) application accepted by the FDA, provided the requirements of LAC 33:XV.713.A.1 are met.La. Admin. Code tit. 33, § XV-741
Promulgated by the Department of Environmental Quality, Office of Air Quality and Radiation Protection, Radiation Protection Division, LR 18:34 (January 1992), amended by the Office of Environmental Assessment, Environmental Planning Division, LR 30:1178 (June 2004), amended by the Office of the Secretary, Legal Affairs Division, LR 32:813 (May 2006), Amended by the Office of the Secretary, Legal Affairs and Criminal Investigations Division, LR 471858 (12/1/2021).AUTHORITY NOTE: Promulgated in accordance with R.S. 30:2001 et seq. and 2104.B.